Corporate News
FONT-SIZE Plus   Neg
Share SHARE

Interesting Stocks To Watch - Nov. 8: FLDM, IDSY, QCOM, EAC, GCA, CTL, NCIT...

RELATED NEWS
Trade GCA now with 

What makes these stocks interesting?

Fluidigm Corp. (FLDM: Quote) Issues FY12 Guidance

- Now expects FY12 product revenue to grow 24% - 26% over prior year's product revenue of $40.6 mln.

- Projects FY12 grant revenue is expected to be about $0.6 mln.

***

I.D. Systems Inc. (IDSY: Quote) Swings To Profit In Q3

- Q3 net income was $2.2 mln or $0.18/Shr versus loss $214K or $0.02 last year.

- Q3 non-GAAP net income was $3.0 mln or $0.25/Shr versus $665K or $0.06 last year. Consensus - $0.27/Shr.

- Q3 revenue rose 37% to $15.5 mln from $11.3 mln a year ago. Consensus - $17.26 mln.

***

Qualcomm Inc. (QCOM: Quote) Q4 Profit Rises; Issues Q1, FY13 Outlook

- Projects Q1 GAAP EPS in the range of $0.90 - $0.98.

- Expects Q1 non-GAAP EPS in the range of $1.08 - $1.16. Consensus - $1.00/Shr.

- Sees Q1 revenues between $5.6 bln and $6.1 bln. Consensus - $5.29 bln.

- Expects FY13 GAAP EPS in the range of $3.40 - $3.60

- Expects FY13 non-GAAP EPS in the range of $4.12 - $4.32. Consensus - $4.13/Shr.

- Projects FY13 revenues in the range of $23.0 bln - $24.0 bln. Consensus - $21.69 bln.

***

Erickson Air-Crane Inc. (EAC: Quote) Lifts FY12 Guidance

- Raises FY12 pro forma EPS target to $1.34 - $1.55 from prior outlook of $0.76 - $0.86. Consensus - $1.10/Shr.

- Lifts FY12 GAAP EPS estimate to a range of $1.86 - $2.15 from prior forecast range of $1.05 - $1.20.

- Now sees FY12 revenues to range between $177.0 mln and $181.0 mln, up from prior view of $159.0 mln - $165.0 mln. Consensus - $162.76 mln.

***

Global Cash Access Holdings Inc. (GCA: Quote) Raises FY12 Outlook

- Lifts FY12 cash EPS target to $0.81 - $0.84 from prior estimate of $0.76 - $0.82. Consensus - $0.79/Shr.

***

CenturyLink Inc. (CTL: Quote) Q3 Profit Rises; Lifts FY12 Adj. EPS View

- Projects Q4 adj. EPS to range between $0.64 and $0.69. Consensus - $0.62/Shr.

- Expects Q4 opt. Revenue in the range of $4.56 bln - $4.61 bln. Consensus - $4.58 bln.

- Lifts FY12 adj. EPS target to $2.64 - $2.69 from prior view of $2.45 - $2.55. Consensus - $2.53/Shr.

- Now sees FY12 opt. revenue in the range of $18.35 bln - $18.4 bln versus prior estimate of $18.3 bln - $18.4 bln. Consensus - $18.37 bln.

***

NCI Inc. (NCIT: Quote) Sees Q4, FY12 Results Above Consensus

- Projects Q4 adj. EPS in the range of $0.10 - $0.12. Consensus - $0.06/Shr.

- Expects Q4 revenue in the range of $85 mln - $91 mln. Consensus - $83.71 mln.

- Expects FY12 adj. EPS to range between $0.46 and $0.48. Consensus - $0.36/Shr.

- Projects FY12 revenue in the range of $364 mln - $370 mln. Consensus - $359.99 mln.

***

Sapient Corp. (SAPE: Quote) Q3 Profit Rises

- Q3 net income was $21.5 mln or $0.15/Shr versus $19.8 mln or $0.14/Shr last year.

- Q3 adj. net income was $28.0 mln or $0.20/Shr versus $25.7 mln or $0.18/Shr last year. Consensus - $0.13/Shr.

- Q3 service revenues grew to $288.5 mln from $262.7 mln last year. Consensus - $281.34 mln.

- Prior to the impact of Hurricane Sandy, the company was expecting Q4 service revenues of $289 mln - $294 mln. The company said it is still assessing the impact, and estimates Q4 revenues to be $1 mln - $2 mln less. Consensus - $281.34 mln.

***

Tower Group Inc. (TWGP: Quote) Turns To Profit In Q3; Sees FY13 opt. EPS Above Consensus

- Projects FY13 operating EPS in the range of $2.85 - $3.05. Consensus - $0.65/Shr.

***

POZEN Achieves Primary Endpoint In Two Late-Stage Studies

Pharmaceutical company POZEN Inc. (POZN: Quote) said patients on its experimental drug PA32540 experienced fewer Gastric Ulcers, while maintaining cardiovascular benefits compared to those on Aspirin alone. The company derived the data from two pivotal Phase 3 trials.

Register
To receive FREE breaking news email alerts for Global Cash Access Holdings, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus